Biovaxys Technology Corp
OTC:BVAXF
Income Statement
Earnings Waterfall
Biovaxys Technology Corp
Income Statement
Biovaxys Technology Corp
| Apr-2020 | Jul-2020 | Jan-2021 | Apr-2021 | Jul-2021 | Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | Apr-2024 | Jul-2024 | Oct-2024 | Jan-2025 | Apr-2025 | Jul-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(4)
|
(4)
|
(3)
|
(6)
|
(6)
|
(6)
|
(6)
|
(3)
|
(4)
|
(5)
|
(5)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(6)
|
(6)
|
(6)
|
(6)
|
(3)
|
(4)
|
(5)
|
(5)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(1)
-45%
|
(2)
-262%
|
(3)
-77%
|
(4)
-20%
|
(6)
-64%
|
(6)
+5%
|
(6)
+7%
|
(6)
0%
|
(4)
+28%
|
(4)
+7%
|
(4)
+7%
|
(3)
+10%
|
(6)
-103%
|
(6)
+8%
|
(6)
+4%
|
(6)
-6%
|
(3)
+45%
|
(4)
-25%
|
(5)
-18%
|
(5)
0%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(9)
|
(10)
|
(1)
|
(1)
|
(0)
|
0
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(1)
-61%
|
(2)
-225%
|
(3)
-77%
|
(4)
-20%
|
(6)
-64%
|
(6)
+5%
|
(6)
+7%
|
(6)
0%
|
(12)
-106%
|
(11)
+2%
|
(12)
-4%
|
(13)
-6%
|
(8)
+39%
|
(6)
+19%
|
(5)
+15%
|
(5)
+7%
|
(4)
+19%
|
(6)
-40%
|
(6)
-14%
|
(6)
+4%
|
|
| Net Income | ||||||||||||||||||||||
| Income from Continuing Operations |
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(12)
|
(11)
|
(12)
|
(13)
|
(8)
|
(6)
|
(5)
|
(5)
|
(4)
|
(6)
|
(6)
|
(6)
|
|
| Net Income (Common) |
(0)
N/A
|
(1)
-59%
|
(2)
-218%
|
(3)
-77%
|
(4)
-20%
|
(6)
-64%
|
(6)
+5%
|
(6)
+7%
|
(6)
0%
|
(12)
-106%
|
(11)
+2%
|
(12)
-4%
|
(13)
-6%
|
(8)
+39%
|
(6)
+19%
|
(5)
+15%
|
(5)
+7%
|
(4)
+19%
|
(6)
-40%
|
(6)
-14%
|
(6)
+4%
|
|
| EPS (Diluted) |
-0.17
N/A
|
-0.24
-41%
|
-0.24
N/A
|
-0.4
-67%
|
-0.47
-17%
|
-0.77
-64%
|
-0.66
+14%
|
-0.58
+12%
|
-0.58
N/A
|
-1.19
-105%
|
-1
+16%
|
-0.91
+9%
|
-0.85
+7%
|
-0.57
+33%
|
-0.42
+26%
|
-0.25
+40%
|
-0.22
+12%
|
-0.2
+9%
|
-0.21
-5%
|
-0.21
N/A
|
-0.2
+5%
|
|